Related Experiment Video
Updated: Sep 13, 2025

Facile Preparation of 4-Substituted Quinazoline Derivatives
Published on: February 15, 2016
Exploring the Anticancer Properties of Quinoxaline-Based Molecules: A Systematic Review
Eman K A Abdelall1, Heba A H Elshemy1, Noha Ryad2
1Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
Abstract:
Cancer is recognized as a major health issue and remains one of the leading causes of death worldwide. Various anticancer agents were synthesized, but most current drugs lack specificity and cause numerous adverse effects associated with chemotherapy. The ongoing research aims to develop novel anticancer agents for future cancer therapies. Quinoxaline derivatives have been shown as a promising compound due to their potential to inhibit various cancer-related pathways and enzymes. This review gathers and presents numerous research studies on the anticancer efficaciousness of quinoxaline derivatives as a treatment and summarizes the results that were carried out between 2015 and 2024.
Insights
Quinoxaline derivatives show promise as novel anticancer agents, offering potential treatments with fewer side effects than traditional chemotherapy. This review highlights their efficacy in combating cancer pathways.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Oncology
Background:
- Cancer remains a leading global cause of death, necessitating new therapeutic strategies.
- Current chemotherapy drugs often lack specificity and cause significant adverse effects.
- Quinoxaline derivatives are emerging as a promising class of compounds for cancer treatment.
Purpose of the Study:
- To review and synthesize research on the anticancer efficacy of quinoxaline derivatives.
- To summarize findings from studies published between 2015 and 2024.
- To highlight the potential of quinoxaline derivatives in future cancer therapies.
Main Methods:
- Comprehensive literature search of scientific databases.
- Inclusion of studies focusing on quinoxaline derivatives' anticancer activity.
- Analysis and summarization of reported efficacy and mechanisms of action.
Main Results:
- Numerous quinoxaline derivatives demonstrate significant anticancer activity against various cancer types.
- These compounds show potential in inhibiting key cancer-related pathways and enzymes.
- The review covers a decade of research (2015-2024) showcasing consistent findings.
Conclusions:
- Quinoxaline derivatives represent a promising scaffold for developing novel anticancer drugs.
- Their targeted action may offer improved specificity and reduced side effects compared to conventional chemotherapy.
- Further research and clinical trials are warranted to fully realize their therapeutic potential.
More Related Videos
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Prevention
Some...
Inhibition of Cdk Activity
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules